Nurse Practitioner, Family · Presque Isle, ME
NPI
1689152357
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
146 Academy St Ste 1b
Presque Isle, ME, 04769
Phone (207) 768-4457
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
1,840 services
Medicare patients, 2024
421
Average age 74
Drug cost, 2024
$3.8M
1,197 prescriptions
Company payments, 2024
$17.38
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelsey E Nadeau was code 17003 (destruction skin lesion), 704 times for 141 patients. In total Kelsey E Nadeau billed 1,840 services in 26 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Facility | 704 | 141 | $1.16 | $813 |
| 99213 Office E&M - Established | Facility | 573 | 414 | $35.23 | $20K |
| 17000 Destruction Skin Lesion | Facility | 238 | 186 | $26.04 | $6,198 |
| 17110 Destruction Skin Lesion | Facility | 136 | 114 | $38.41 | $5,224 |
| 11102 Skin Biopsy | Facility | 84 | 79 | $13.57 | $1,139 |
| 11900 Skin | Facility | 27 | 23 | $12.74 | $344 |
| 11103 Skin Biopsy | Facility | 24 | 15 | $13.06 | $313 |
By year: 2022 $34K for 1,581 services; 2023 $43K for 2,254 services; 2024 $36K for 1,840 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelsey E Nadeau prescribed most often to Medicare patients was Cosentyx Sensoready (2 Pens) (Secukinumab), with 173 prescriptions and refills. In total Kelsey E Nadeau wrote 1,197 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cosentyx Sensoready (2 Pens) Secukinumab | 173 | 178 | 18 | $1.4M |
| Triamcinolone Acetonide Generic | 135 | 144 | 85 | $1,276 |
| Clobetasol Propionate Generic | 113 | 124 | 63 | $4,683 |
| Humira Pen Adalimumab | 58 | 58 | 11 | $459K |
| Tacrolimus Generic | 54 | 59 | 36 | $7,259 |
| Metronidazole Generic | 49 | 55 | 24 | $3,318 |
| Otezla Apremilast | 45 | 45 | Under 11 | $208K |
| Dupixent Pen Dupilumab | 42 | 43 | Under 11 | $166K |
| Tremfya Guselkumab | 41 | 67 | Under 11 | $576K |
| Methotrexate Methotrexate Sodium | 39 | 69 | Under 11 | $382 |
| Doxycycline Monohydrate Generic | 36 | 41 | 14 | $376 |
| Dupixent Syringe Dupilumab | 35 | 35 | Under 11 | $130K |
| Fluorouracil Generic | 28 | 31 | 26 | $1,990 |
| Ammonium Lactate Generic | 20 | 28 | 12 | $647 |
| Stelara Ustekinumab | 20 | 43 | Under 11 | $415K |
Brand drugs: 498 claims; generic drugs: 699 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kelsey E Nadeau $17.38 ($17.38 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $17.38.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.